Coronaviruses
Title:Vitamin D3 Deficiency and COVID-19
Volume: 2 Issue: 1
Author(s): Olen R. Brown*Martin R. Hullender
Affiliation:
- Dalton Cardiovascular Research Center, University of Missouri- Columbia, MO,United States
Export Options
About this article
Cite this article as:
Brown R. Olen *, Hullender R. Martin , Vitamin D3 Deficiency and COVID-19, Coronaviruses 2021; 2 (1) . https://dx.doi.org/10.2174/2666796701999200914112352
DOI https://dx.doi.org/10.2174/2666796701999200914112352 |
Print ISSN 2666-7967 |
Publisher Name Bentham Science Publisher |
Online ISSN 2666-7975 |
10
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Materials Degradation in PVC Medical Devices, DEHP Leaching and Neonatal Outcomes
Current Medicinal Chemistry Ureas: Applications in Drug Design
Current Medicinal Chemistry SARS-CoV-2: An Insight into Detection Tools
Infectious Disorders - Drug Targets Specificity of Binding in Protein Kinases
Current Enzyme Inhibition Chemistry and Anticancer Activity of Hybrid Molecules and Derivatives based on 5-Fluorouracil
Current Medicinal Chemistry Antiviral Drug Discovery Against SARS-CoV
Current Medicinal Chemistry Targeting Tuberculosis Through Diversity Oriented Synthesis (DOS) of Hydrazide Frameworks and Evaluation of Mycobacterium Activity Thereof
Current Organic Chemistry The Pathogenic Subpopulation of Th17 Cells in Obesity
Current Pharmaceutical Design Outlining the Molecules Tested <i>In Vivo</i> for Chagas Disease, Malaria, and Schistosomiasis Over the Last Six Years - A Literature Review Focused on New Synthetic Drug Identities and Repurposing Strategies
Current Medicinal Chemistry Modular Protein Engineering in Emerging Cancer Therapies
Current Pharmaceutical Design Plant Natural Products as a Potential Source for Antibacterial Agents: Recent Trends
Anti-Infective Agents in Medicinal Chemistry Synthesis of 2-Thiohydantoins as Somatostatin Subtype 4 Receptor Ligands
Letters in Drug Design & Discovery Recent Development of Multifunctional Agents as Potential Drug Candidates for the Treatment of Alzheimer’s Disease
Current Medicinal Chemistry Recent Patents on Biomedical Devices and Nanomaterials for Hyperthermal Therapy of Cancer
Recent Patents on Nanomedicine 1,3,5-Triazine Analogs: A Potent Anticancer Scaffold
Current Signal Transduction Therapy A Perspective on the Impact of COVID-19 Pandemic on Basic Science Research and its Future Implications
Coronaviruses Inhibition Studies on Enzymes Involved in Isoprenoid Biosynthesis. Focus on Two Potential Drug Targets: DXR and IDI-2 Enzymes
Current Enzyme Inhibition Synthesis, Testing and Structure-Activity Studies on a Library of 5-HT4 Ligands
Medicinal Chemistry Scope and Limitation of Ligand Docking: Methods, Scoring Functions and Protein Targets
Current Computer-Aided Drug Design Fragment-Based Drug Design: Computational and Experimental State of the Art
Combinatorial Chemistry & High Throughput Screening